Technical advance: ascorbic acid induces development of double-positive T cells from human hematopoietic stem cells in the absence of stromal cells.
Level 5 - mechanism / opinion, no new human data
In vitro bench study examining cell differentiation mechanisms without clinical subjects.
PubMed 25157026 · doi:10.1189/jlb.1TA0214-121RR
What was done
Researchers investigated the role of ascorbic acid in human T cell development in vitro using cord blood and G-CSF-mobilized hematopoietic stem cells. Cells were cultured in defined, feeder-free conditions with Notch ligands and growth factors, or in feeder cocultures, with and without ascorbic acid and nitric oxide synthase (NOS) inhibitors.
What was found
The abstract reports no numerical values. Qualitatively, adding ascorbic acid promoted differentiation from proT1 to proT2 and preT to double-positive T cells in the absence of DLL4-expressing feeder cells or conditioned media. In feeder cocultures, ascorbic acid allowed progression to double-positive and single-positive T cells (which arrested at the preT stage without ascorbic acid), an effect diminished by NOS inhibition.
Why it matters
This technical advance provides a feeder-free method to generate early T-cell progenitors in vitro, which could simplify manufacturing for adoptive cell therapies aimed at accelerating immune recovery after hematopoietic stem cell transplantation.
Limits
The abstract provides no quantitative data, sample sizes, or statistical metrics. Findings are entirely limited to in vitro cell culture, with no in vivo engraftment, immune reconstitution, or clinical efficacy data.
Cited by
- supports Multiple in vitro studies in mouse and human cell lines have demonstrated that culturing T cells with vitamin C can enhance T cell development.